The role of industry in the development of a product for control of mycoplasmal plant diseases.
A number of mycoplasmal or mycoplasma-like diseases of plants have been treated with an oxytetracycline-based product. Remission of symptoms has generally resulted, and in some instances the local use of this product under temporary governmental registrations has been approved. The use of oxytetracycline for control of many such diseases is not commercially feasible because the potential market is relatively small and the costs of development are relatively high. However, oxytetracycline products may be useful when a disease problem becomes sufficiently serious to arouse academic attention and agricultural or public concern. The commercial use of oxytetracycline hydrochloride for remission and prevention of lethal yellowing of coconut palm was begun in 1974. Use of this product for control of pear decline disease followed shortly thereafter. To date, joint participation and cooperation of the drug and agricultural industries have also resulted in the control of two important mycoplasma-like diseases of peach trees in the United States.
D001673:Biodegradation, Environmental; D004352:Drug Resistance, Microbial; D005638:Fruit / Q000032:analysis; D009174:Mycoplasma / Q000187:drug effects*; D010118:Oxytetracycline / Q000032:analysis / Q000378:metabolism / Q000494:pharmacology*; D010935:Plant Diseases; D010944:Plants / Q000378:metabolism
D010118:Oxytetracycline